Market Place
Sourcing Support
All News #Library
Others
Ami Lifesciences announce offering of Lumateperone Tosylate
25 Aug 2025 //
PRESS RELEASE
Ami Lifesciences at J.P. Morgan Healthcare Conference 2025
17 Mar 2025 //
PRESS RELEASE
Ami Secures Key CEP Approval For Sitagliptin Phosphate Monohydrate
17 Mar 2025 //
PRESS RELEASE
Ami Lifesciences Submits US DMF for Tegoprazan
08 Oct 2024 //
PRESS RELEASE
Oxcarbazepine Receives CEP Approval from EDQM
02 Aug 2024 //
PRESS RELEASE
Ami Lifesciences Gets CADIFA Approval for Vonoprazan
02 Aug 2024 //
PRESS RELEASE
Ami Have Received Cep Approval For Rivaroxaban,Used An Anti-Coagulating Agent
08 Apr 2024 //
PRESS RELEASE
Ami received CEP approval Gliclazide. With this approval, we`re one step closer
01 Mar 2024 //
PRESS RELEASE
Ami successful filing of the USDMF for Sitagliptin Phosphate Monohydrate
23 Jan 2024 //
PRESS RELEASE
Ami Lifesciences the USDMF submission of Mirogablin Besylate to the US FDA
01 Jan 2024 //
PRESS RELEASE
Ami Lifesciences appoints Amit Kaptain as CEO
16 Sep 2022 //
HEALTH ECONOMIC TIMES
Inaugurated new kilo plant which caters to high value low volume APIs
18 Aug 2021 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.